{
  "DOI": "10.1186/s40246-021-00340-5",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-021-00340-5",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eAcute myeloid leukemia (AML) is recognized as a hematological neoplasm with heterogenetic cytology and short-term outcome. HCP5 has been proven to be related with the pathogenesis of AML. However, the underlying mechanism of HCP5 in AML remains unclear.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMethods\u003c/jats:title\u003e\n                \u003cjats:p\u003eClinical profiles of AML patients were downloaded from TCGA and GTEx databases. LncBase and TargetScan online tools were utilized to predict potential targets, and dual-luciferase reporter assay was performed to verify the association between miR-1291 and HCP5 or PIK3R5. Cell Counting Kit 8 and flow cytometry tests were implemented to evaluate the effects of HCP5/miR-1291/PIK3R5 axis in AML cells. Quantitative RT-PCR and Western blot were conducted to detect the expression levels of genes.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eHCP5 and PIK3R5 were significantly increased in AML tissue samples compared with healthy controls. HCP5 facilitated AML cells viability and inhibited apoptosis. There was a positive relationship between HCP5 and PIK3R5, but miR-1291 negatively regulated PIK3R5. Overexpression of PIK3R5 enhanced the promoting effect of HCP5 in the development of AML, while weakened the suppression of miR-1291 to AML progression.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusion\u003c/jats:title\u003e\n                \u003cjats:p\u003eOur findings manifested that HCP5 was remarkably upregulated in AML and upregulated HCP5 promoted the malignant behaviors of AML cells by mediating miR-1291/PIK3R5 axis, which would provide a new insight for the treatment of AML.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "340"
  ],
  "article-number": "38",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "22 September 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "15 June 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "29 June 2021"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Liu",
      "given": "Yan",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Jing",
      "given": "Xue-Bing",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Zhen-Cheng",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-5468-2137",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Han",
      "given": "Qing-Kun",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        6,
        29
      ]
    ],
    "date-time": "2021-06-29T15:08:18Z",
    "timestamp": 1624979298000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        6,
        29
      ]
    ],
    "date-time": "2021-06-29T15:10:42Z",
    "timestamp": 1624979442000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        1
      ]
    ],
    "date-time": "2024-02-01T22:09:21Z",
    "timestamp": 1706825361956
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2021,
        6,
        29
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2021,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            6,
            29
          ]
        ],
        "date-time": "2021-06-29T00:00:00Z",
        "timestamp": 1624924800000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            6,
            29
          ]
        ],
        "date-time": "2021-06-29T00:00:00Z",
        "timestamp": 1624924800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-021-00340-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-021-00340-5/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-021-00340-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2021,
        6,
        29
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        6,
        29
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3390/genes10080614",
      "doi-asserted-by": "crossref",
      "key": "340_CR1",
      "unstructured": "Skayneh H, Jishi B, Hleihel R, Hamieh M, Darwiche N, Bazarbachi A, et al. A critical review of animal models used in acute myeloid leukemia pathophysiology. Genes (Basel). 2019;10:1–35."
    },
    {
      "DOI": "10.1007/s10552-007-9097-2",
      "author": "JF Yamamoto",
      "doi-asserted-by": "publisher",
      "first-page": "379",
      "issue": "4",
      "journal-title": "Cancer Causes Control.",
      "key": "340_CR2",
      "unstructured": "Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer Causes Control. 2008;19(4):379–90. https://doi.org/10.1007/s10552-007-9097-2.",
      "volume": "19",
      "year": "2008"
    },
    {
      "DOI": "10.3324/haematol.2010.026252",
      "author": "M Maynadié",
      "doi-asserted-by": "publisher",
      "first-page": "55",
      "issue": "1",
      "journal-title": "Haematologica.",
      "key": "340_CR3",
      "unstructured": "Maynadié M, Girodon F, Manivet-Janoray I, Mounier M, Mugneret F, Bailly F, et al. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d’Or (Burgundy, France). Haematologica. 2011;96(1):55–61. https://doi.org/10.3324/haematol.2010.026252.",
      "volume": "96",
      "year": "2011"
    },
    {
      "DOI": "10.1056/NEJMra1406184",
      "author": "H Döhner",
      "doi-asserted-by": "publisher",
      "first-page": "1136",
      "issue": "12",
      "journal-title": "N Engl J Med.",
      "key": "340_CR4",
      "unstructured": "Döhner H, Weisdorf DJ, Bloomfield CD. Acute Myeloid Leukemia. N Engl J Med. 2015;373(12):1136–52. https://doi.org/10.1056/NEJMra1406184.",
      "volume": "373",
      "year": "2015"
    },
    {
      "DOI": "10.1182/blood-2016-08-733196",
      "author": "H Döhner",
      "doi-asserted-by": "publisher",
      "first-page": "424",
      "issue": "4",
      "journal-title": "Blood.",
      "key": "340_CR5",
      "unstructured": "Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–47. https://doi.org/10.1182/blood-2016-08-733196.",
      "volume": "129",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.abb.2019.108244",
      "author": "L Chen",
      "doi-asserted-by": "publisher",
      "first-page": "108244",
      "journal-title": "Arch Biochem Biophys.",
      "key": "340_CR6",
      "unstructured": "Chen L, Hu N, Wang C, Zhao H. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells. Arch Biochem Biophys. 2020;680:108244. https://doi.org/10.1016/j.abb.2019.108244.",
      "volume": "680",
      "year": "2020"
    },
    {
      "DOI": "10.18632/oncotarget.4069",
      "author": "JM Hughes",
      "doi-asserted-by": "publisher",
      "first-page": "18534",
      "issue": "21",
      "journal-title": "Oncotarget.",
      "key": "340_CR7",
      "unstructured": "Hughes JM, Legnini I, Salvatori B, Masciarelli S, Marchioni M, Fazi F, et al. C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia. Oncotarget. 2015;6(21):18534–44. https://doi.org/10.18632/oncotarget.4069.",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pgen.1000041",
      "author": "Y Liu",
      "doi-asserted-by": "publisher",
      "issue": "4",
      "journal-title": "PLoS Genet.",
      "key": "340_CR8",
      "unstructured": "Liu Y, Helms C, Liao W, Zaba LC, Duan S, Gardner J, et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 2008;4(4):e1000041. https://doi.org/10.1371/journal.pgen.1000041.",
      "volume": "4",
      "year": "2008"
    },
    {
      "DOI": "10.2147/OTT.S222703",
      "author": "Y Liu",
      "doi-asserted-by": "publisher",
      "first-page": "8207",
      "journal-title": "Onco Targets Ther.",
      "key": "340_CR9",
      "unstructured": "Liu Y, Wang J, Dong L, Xia L, Zhu H, Li Z, et al. Long noncoding RNA HCP5 regulates pancreatic cancer gemcitabine (GEM) resistance by sponging Hsa-miR-214-3p to target HDGF. Onco Targets Ther. 2019;12:8207–16. https://doi.org/10.2147/OTT.S222703.",
      "volume": "12",
      "year": "2019"
    },
    {
      "DOI": "10.26355/eurrev_201904_17553",
      "author": "WK Yun",
      "doi-asserted-by": "publisher",
      "first-page": "2786",
      "issue": "7",
      "journal-title": "Eur Rev Med Pharmacol Sci.",
      "key": "340_CR10",
      "unstructured": "Yun WK, Hu YM, Zhao CB, Yu DY, Tang JB. HCP5 promotes colon cancer development by activating AP1G1 via PI3K/AKT pathway. Eur Rev Med Pharmacol Sci. 2019;23(7):2786–93. https://doi.org/10.26355/eurrev_201904_17553.",
      "volume": "23",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.biopha.2019.108966",
      "author": "J Chen",
      "doi-asserted-by": "publisher",
      "first-page": "108966",
      "journal-title": "Biomed Pharmacother.",
      "key": "340_CR11",
      "unstructured": "Chen J, Zhao D, Meng Q. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer. Biomed Pharmacother. 2019;116:108966. https://doi.org/10.1016/j.biopha.2019.108966.",
      "volume": "116",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s00210-019-01788-y",
      "author": "M Lei",
      "doi-asserted-by": "publisher",
      "first-page": "1025",
      "issue": "6",
      "journal-title": "Naunyn Schmiedebergs Arch Pharmacol.",
      "key": "340_CR12",
      "unstructured": "Lei M, Jingjing Z, Tao J, Jianping M, Yuanxin Z, Jifeng W, et al. LncRNA HCP5 promotes LAML progression via PSMB8-mediated PI3K/AKT pathway activation. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(6):1025–32. https://doi.org/10.1007/s00210-019-01788-y.",
      "volume": "393",
      "year": "2020"
    },
    {
      "DOI": "10.1002/humu.21650",
      "author": "N Al Tassan",
      "doi-asserted-by": "publisher",
      "first-page": "351",
      "issue": "2",
      "journal-title": "Hum Mutat.",
      "key": "340_CR13",
      "unstructured": "Al Tassan N, Khalil D, Shinwari J, Al Sharif L, Bavi P, Abduljaleel Z, et al. A missense mutation in PIK3R5 gene in a family with ataxia and oculomotor apraxia. Hum Mutat. 2012;33(2):351–4. https://doi.org/10.1002/humu.21650.",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.2119/molmed.2009.00159",
      "author": "JE Rose",
      "doi-asserted-by": "publisher",
      "first-page": "247",
      "issue": "7-8",
      "journal-title": "Mol Med.",
      "key": "340_CR14",
      "unstructured": "Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR. Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Mol Med. 2010;16(7-8):247–53. https://doi.org/10.2119/molmed.2009.00159.",
      "volume": "16",
      "year": "2010"
    },
    {
      "DOI": "10.4143/crt.2018.405",
      "author": "LY Li",
      "doi-asserted-by": "publisher",
      "first-page": "1117",
      "issue": "3",
      "journal-title": "Cancer Res Treat.",
      "key": "340_CR15",
      "unstructured": "Li LY, Kim HJ, Park SA, Lee SH, Kim LK, Lee JY, et al. Genetic profiles associated with chemoresistance in patient-derived xenograft models of ovarian cancer. Cancer Res Treat. 2019;51(3):1117–27. https://doi.org/10.4143/crt.2018.405.",
      "volume": "51",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s12943-019-0952-z",
      "author": "N Mittal",
      "doi-asserted-by": "publisher",
      "first-page": "30",
      "issue": "1",
      "journal-title": "Mol Cancer.",
      "key": "340_CR16",
      "unstructured": "Mittal N, Li L, Sheng Y, Hu C, Li F, Zhu T, et al. A critical role of epigenetic inactivation of miR-9 in EVI1(high) pediatric AML. Mol Cancer. 2019;18(1):30. https://doi.org/10.1186/s12943-019-0952-z.",
      "volume": "18",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41375-018-0015-2",
      "author": "D Peng",
      "doi-asserted-by": "publisher",
      "first-page": "1180",
      "journal-title": "Leukemia",
      "key": "340_CR17",
      "unstructured": "Peng D, Wang H, Li L, Ma X, Chen Y, Zhou H, et al. miR-34c-5p promotes eradication of acute myeloid leukemia stem cells by inducing senescence through selective RAB27B targeting to inhibit exosome shedding. Leukemia. 2018;32:1180–8.",
      "volume": "32",
      "year": "2018"
    },
    {
      "DOI": "10.1182/blood-2016-06-721027",
      "author": "J Liu",
      "doi-asserted-by": "publisher",
      "first-page": "1491",
      "journal-title": "Blood",
      "key": "340_CR18",
      "unstructured": "Liu J, Guo B, Chen Z, Wang N, Iacovino M, Cheng J, et al. miR-125b promotes MLL-AF9-driven murine acute myeloid leukemia involving a VEGFA-mediated non-cell-intrinsic mechanism. Blood. 2017;129:1491–502.",
      "volume": "129",
      "year": "2017"
    },
    {
      "DOI": "10.1111/cas.12240",
      "author": "T Yamasaki",
      "doi-asserted-by": "publisher",
      "first-page": "1411",
      "issue": "11",
      "journal-title": "Cancer Sci.",
      "key": "340_CR19",
      "unstructured": "Yamasaki T, Seki N, Yoshino H, Itesako T, Yamada Y, Tatarano S, et al. Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma. Cancer Sci. 2013;104(11):1411–9. https://doi.org/10.1111/cas.12240.",
      "volume": "104",
      "year": "2013"
    },
    {
      "DOI": "10.1002/pros.22961",
      "author": "M Scaravilli",
      "doi-asserted-by": "publisher",
      "first-page": "798",
      "issue": "8",
      "journal-title": "Prostate.",
      "key": "340_CR20",
      "unstructured": "Scaravilli M, Porkka KP, Brofeldt A, Annala M, Tammela TL, Jenster GW, et al. MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2. Prostate. 2015;75(8):798–805. https://doi.org/10.1002/pros.22961.",
      "volume": "75",
      "year": "2015"
    },
    {
      "DOI": "10.3892/or.2015.4206",
      "author": "H Luo",
      "doi-asserted-by": "publisher",
      "first-page": "2665",
      "journal-title": "Oncol Rep",
      "key": "340_CR21",
      "unstructured": "Luo H, Guo W, Wang F, You Y, Wang J, Chen X, et al. miR-1291 targets mucin 1 inhibiting cell proliferation and invasion to promote cell apoptosis in esophageal squamous cell carcinoma. Oncol Rep. 2015;34:2665–73.",
      "volume": "34",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.prp.2018.12.006",
      "author": "W Zhao",
      "doi-asserted-by": "publisher",
      "first-page": "439",
      "issue": "3",
      "journal-title": "Pathol Res Pract.",
      "key": "340_CR22",
      "unstructured": "Zhao W, Li L. SP1-induced upregulation of long non-coding RNA HCP5 promotes the development of osteosarcoma. Pathol Res Pract. 2019;215(3):439–45. https://doi.org/10.1016/j.prp.2018.12.006.",
      "volume": "215",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.jhep.2013.04.032",
      "author": "CM Lange",
      "doi-asserted-by": "publisher",
      "first-page": "504",
      "issue": "3",
      "journal-title": "J Hepatol.",
      "key": "340_CR23",
      "unstructured": "Lange CM, Bibert S, Dufour JF, Cellerai C, Cerny A, Heim MH, et al. Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. J Hepatol. 2013;59(3):504–9. https://doi.org/10.1016/j.jhep.2013.04.032.",
      "volume": "59",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.yexmp.2020.104415",
      "author": "S Ghafouri-Fard",
      "doi-asserted-by": "publisher",
      "first-page": "104415",
      "journal-title": "Exp Mol Pathol.",
      "key": "340_CR24",
      "unstructured": "Ghafouri-Fard S, Taherian-Esfahani Z, Dashti S, Kholghi Oskooei V, Taheri M, Samsami M. Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer. Exp Mol Pathol. 2020;114:104415. https://doi.org/10.1016/j.yexmp.2020.104415.",
      "volume": "114",
      "year": "2020"
    },
    {
      "DOI": "10.26355/eurrev_201808_15616",
      "author": "Y Yu",
      "doi-asserted-by": "publisher",
      "first-page": "4812",
      "issue": "15",
      "journal-title": "Eur Rev Med Pharmacol Sci.",
      "key": "340_CR25",
      "unstructured": "Yu Y, Shen HM, Fang DM, Meng QJ, Xin YH. LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a. Eur Rev Med Pharmacol Sci. 2018;22(15):4812–9. https://doi.org/10.26355/eurrev_201808_15616.",
      "volume": "22",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s12881-019-0832-9",
      "author": "Q Zhao",
      "doi-asserted-by": "publisher",
      "first-page": "103",
      "issue": "1",
      "journal-title": "BMC Med Genet.",
      "key": "340_CR26",
      "unstructured": "Zhao Q, Fan C. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs. BMC Med Genet. 2019;20(1):103. https://doi.org/10.1186/s12881-019-0832-9.",
      "volume": "20",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s12935-018-0653-5",
      "author": "Z Wang",
      "doi-asserted-by": "publisher",
      "first-page": "161",
      "issue": "1",
      "journal-title": "Cancer Cell Int.",
      "key": "340_CR27",
      "unstructured": "Wang Z, Lu B, Sun L, Yan X, Xu J. Identification of candidate genes or microRNAs associated with the lymph node metastasis of SCLC. Cancer Cell Int. 2018;18(1):161. https://doi.org/10.1186/s12935-018-0653-5.",
      "volume": "18",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.mce.2019.110697",
      "author": "Y Chen",
      "doi-asserted-by": "publisher",
      "first-page": "110697",
      "journal-title": "Mol Cell Endocrinol.",
      "key": "340_CR28",
      "unstructured": "Chen Y, Zhang X, An Y, Liu B, Lu M. LncRNA HCP5 promotes cell proliferation and inhibits apoptosis via miR-27a-3p/IGF-1 axis in human granulosa-like tumor cell line KGN. Mol Cell Endocrinol. 2020;503:110697. https://doi.org/10.1016/j.mce.2019.110697.",
      "volume": "503",
      "year": "2020"
    },
    {
      "DOI": "10.1371/journal.pone.0098965",
      "author": "S Das",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS One",
      "key": "340_CR29",
      "unstructured": "Das S, Ghosal S, Sen R, Chakrabarti J. lnCeDB: database of human long noncoding RNA acting as competing endogenous RNA. PLoS One. 2014;9:e98965.",
      "volume": "9",
      "year": "2014"
    },
    {
      "DOI": "10.7150/thno.31097",
      "author": "L Jiang",
      "doi-asserted-by": "publisher",
      "first-page": "2460",
      "issue": "9",
      "journal-title": "Theranostics.",
      "key": "340_CR30",
      "unstructured": "Jiang L, Wang R, Fang L, Ge X, Chen L, Zhou M, et al. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis. Theranostics. 2019;9(9):2460–74. https://doi.org/10.7150/thno.31097.",
      "volume": "9",
      "year": "2019"
    },
    {
      "DOI": "10.1515/jpem-2018-0432",
      "author": "R Chen",
      "doi-asserted-by": "publisher",
      "first-page": "1327",
      "issue": "12",
      "journal-title": "J Pediatr Endocrinol Metab.",
      "key": "340_CR31",
      "unstructured": "Chen R, Xin G, Zhang X. Long non-coding RNA HCP5 serves as a ceRNA sponging miR-17-5p and miR-27a/b to regulate the pathogenesis of childhood obesity via the MAPK signaling pathway. J Pediatr Endocrinol Metab. 2019;32(12):1327–39. https://doi.org/10.1515/jpem-2018-0432.",
      "volume": "32",
      "year": "2019"
    },
    {
      "DOI": "10.18632/oncotarget.9999",
      "author": "MJ Tu",
      "doi-asserted-by": "publisher",
      "first-page": "45547",
      "issue": "29",
      "journal-title": "Oncotarget.",
      "key": "340_CR32",
      "unstructured": "Tu MJ, Pan YZ, Qiu JX, Kim EJ, Yu AM. MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis. Oncotarget. 2016;7(29):45547–61. https://doi.org/10.18632/oncotarget.9999.",
      "volume": "7",
      "year": "2016"
    },
    {
      "DOI": "10.1124/dmd.115.064493",
      "author": "MM Li",
      "doi-asserted-by": "publisher",
      "first-page": "1129",
      "issue": "7",
      "journal-title": "Drug Metab Dispos.",
      "key": "340_CR33",
      "unstructured": "Li MM, Addepalli B, Tu MJ, Chen QX, Wang WP, Limbach PA, et al. Chimeric MicroRNA-1291 biosynthesized efficiently in Escherichia coli is effective to reduce target gene expression in human carcinoma cells and improve chemosensitivity. Drug Metab Dispos. 2015;43(7):1129–36. https://doi.org/10.1124/dmd.115.064493.",
      "volume": "43",
      "year": "2015"
    },
    {
      "DOI": "10.3892/ol.2019.9980",
      "author": "Q Cai",
      "doi-asserted-by": "publisher",
      "first-page": "3253",
      "issue": "3",
      "journal-title": "Oncol Lett.",
      "key": "340_CR34",
      "unstructured": "Cai Q, Zhao A, Ren L, Chen J, Liao K, Wang Z, et al. MicroRNA-1291 mediates cell proliferation and tumorigenesis by downregulating MED1 in prostate cancer. Oncol Lett. 2019;17(3):3253–60. https://doi.org/10.3892/ol.2019.9980.",
      "volume": "17",
      "year": "2019"
    }
  ],
  "reference-count": 34,
  "references-count": 34,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-021-00340-5"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "HCP5, as the sponge of miR-1291, facilitates AML cell proliferation and restrains apoptosis via increasing PIK3R5 expression"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "15"
}